Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof

BACKGROUND: Stereotactic body radio therapy (SBRT) has emerged as a standard treatment option for nonsurgical candidates with early-stage non-small cell lung cancer (NSCLC). Pathological proof is sometimes difficult to obtain in patients with solitary pulmonary nodules (SPNs). We aimed to compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shaonan, Zhang, Qi, Chen, Jingyao, Chen, Gang, Zhu, Jiangyi, Li, Tingting, Xiao, Han, Du, Shisuo, Zeng, Zhaochong, He, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996902/
https://www.ncbi.nlm.nih.gov/pubmed/36890550
http://dx.doi.org/10.1186/s13014-023-02229-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996902/
https://www.ncbi.nlm.nih.gov/pubmed/36890550
http://dx.doi.org/10.1186/s13014-023-02229-0

Ejemplares similares